Correlation Between Steroid-Induced Osteonecrosis of The Femoral Head and Hepatic CYP3A Activity: A Systematic Review and Meta-Analysis

REFERENCES

• Iwakiri K, Oda Y, Kaneshiro Y, et al. Effect of simvastatin on steroid-induced osteonecrosis evidenced by the serum lipid level and hepatic cytochrome P4503A in a rabbit model. J Orthop Sci. 2008;13(5):463–468.
   PubMed Web of Science ®Google Scholar
• Yamamoto C, Tanaka Y, Sasaki T, et al. Contralateral osteonecrosis of the femoral head newly developed after increasing the dose of corticosteroids. J Orthop Sci. 2015;20(4):772–775.
   PubMed Web of Science ®Google Scholar
• Kubo T, Ueshima K, Saito M, et al. Clinical and basic research on steroid-induced osteonecrosis of the femoral head in Japan ☆. J Orthop Sci. 2016;21(4):407–413.
   PubMed Web of Science ®Google Scholar
• Amanatullah DF, Strauss EJ, Di CP. Current management options for osteonecrosis of the femoral head: part 1, diagnosis and nonoperative management. Am J Orthop. 2011;40(10):216–225.
   Google Scholar
• Filipa M, Jérôme M, Amélia P R, et al. Clinical condition of steroid-induced osteonecrosis of the femoral head. Clin Calcium. 2007;17(6):856–862.
   PubMedGoogle Scholar
• Delling G. Pathohistology of femoral head necrosis. Der Orthop. 2007;36(5):404–406.
   PubMed Web of Science ®Google Scholar
• Hedley AK, Kim W. Prosthetic replacement in osteonecrosis of the hip. Instr Course Lect. 1983;32:265–271.
   PubMedGoogle Scholar
• Hattrup SJ, Cofield RH. Osteonecrosis of the humeral head: relationship of disease stage, extent, and cause to natural history. J Shoulder Elbow Surg. 1999;8(6):559–564.
   PubMed Web of Science ®Google Scholar
• Kerachian MA, Séguin C, Harvey EJ. Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action. Journal of Steroid Biochemistry & Molecular Biology. 2009;114(3–5):121–128.
   PubMed Web of Science ®Google Scholar
• Santes-Palacios R, Ornelasayala D, Cabañas N, et al. Regulation of Human Cytochrome P4501A1 (hCYP1A1): A Plausible Target for Chemoprevention?[J]. BioMed Research International. 2016, (2016-12-26), 2016, 2016(10):1–17.
   Google Scholar
• Masada T, Iwakiri K, Oda Y, et al. Increased hepatic cytochrome P4503A activity decreases the risk of developing steroid-induced osteonecrosis in a rabbit model. Jf Orthop Res. 2008;26(1):91–95.
   Google Scholar
• Tokuhara Y, Wakitani S, Oda Y, et al. Low levels of steroid-metabolizing hepatic enzyme (cytochrome P450 3A) activity may elevate responsiveness to steroids and may increase risk of steroid-induced osteonecrosis even with low glucocorticoid dose. J Orthop Sci. 2009;14(6):794–800.
   PubMed Web of Science ®Google Scholar
• Ikemura S, Yamamoto T, Motomura G, et al. Cytochrome P4503A activity affects the gender difference in the development of steroid-induced osteonecrosis in rabbits. Int J Exp Pathol. 2014;95(2):147.
   PubMed Web of Science ®Google Scholar
• Fei T, Shao Y, Yan Z, et al. The effects of P-gp and CYP450 modulated by rifampicin on the steroid-induced osteonecrosis of the femoral head. [J]. Journal of Bone & Mineral Metabolism, 2016:1–9.
   Web of Science ®Google Scholar
• Liu W, He W, Xu X, et al. A study on the correlation between steroid-induced avascular necrosis of femoral head in rabbits and activity of cytochrome P4503A enzyme in liver cell. J Tradit Chin orthop Traumatol. 2011;23(10):6–9.
   Google Scholar
• Duan R, Liu W, Qu Y. Induction of CYP3A in liver cell of rabbits and prevention of steroid-induced osteonecrosis of femoral head by “GU KANG”. Guiding J Tradit Chin Med Pharmacol. 2013;(7):10–13.
   Google Scholar
• Asano T, Takahashi KA, Fujioka M, et al. Genetic analysis of steroid-induced osteonecrosis of the femoral head. J Orthop Sci. 2003;8(3):329–333.
   PubMedGoogle Scholar
• Tamura K, Nakajima S, Hirota Y, et al. Genetic association of a polymorphism of the cAMP-responsive element binding protein-binding protein with steroid-induced osteonecrosis after kidney transplantation. J Bone Miner Metab. 2007;25(5):320–325.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li X, Gao Y, et al. Genetic polymorphisms of CYP3A4 among Chinese patients with steroid-induced osteonecrosis of the femoral head. Med. 2016;95(44):e5332.
   PubMed Web of Science ®Google Scholar
• He W, Li K. Incidence of genetic polymorphisms involved in lipid metabolism among Chinese patients with osteonecrosis of the femoral head. Acta Orthop. 2009;80(3):325.
   PubMed Web of Science ®Google Scholar
• Nafziger AN, Jr JSB. Low Hepatic cytochrome P450 3A activity is a risk for corticosteroid-induced osteonecrosis. Clin Pharmacol Ther. 2007;82(4):379; author reply 380.
   PubMed Web of Science ®Google Scholar
• Cruess RL. Steroid-induced osteonecrosis: a review. Can J Surg J Can De Chir. 1981;24(6):567–571.
   PubMed Web of Science ®Google Scholar
• Koo KH, Kim R, Kim YS, et al. Risk period for developing osteonecrosis of the femoral head in patients on steroid treatment. Clin Rheumatol. 2002;21(4):299–303.
   PubMed Web of Science ®Google Scholar
• Weinstein RS. Glucocorticoid-induced osteonecrosis. Endocr. 2012;41(2):183.
   Google Scholar
• Zhang NF, Li ZR, Wei HY, et al. Steroid-induced osteonecrosis. J Bone Joint Surg Br Volume. 2008;90(9):1239–1243.
   PubMedGoogle Scholar
• Wang, GwoJaw, Cui, et al. The pathogenesis and prevention of steroid induced osteonecrosis. Clin Orthop Relat Res. 1999;370(370):295–310.
   Google Scholar
• Caplan A, Fett N, Rosenbach M, et al. Prevention and management of glucocorticoid-induced side effects: a comprehensive review: Infectious complications and vaccination recommendations. J Am Acad Dermatol. 2017;76(2):191.
   PubMed Web of Science ®Google Scholar
• Katsuki I, Shangang Yang. Treatment for steroid-induced osteonecrosis of the femoral head. Japanese J Joint Dis. 2010;8:267–274.
   Google Scholar
• Mont MA, Hungerford DS. Steroid-associated osteonecrosis of the knee: a comprehensive review. Instr Course Lect. 2001;50:489–493.
   PubMedGoogle Scholar
• YINLi, LIYue-bai, WANGYi-sheng. Dexamethasone-induced adipogenesis in primary marrow stromal cell cultures: mechanism of steroid-induced osteonecrosis. Chin Med J. 2006;119(7):581–588.
   PubMed Web of Science ®Google Scholar
• Kaneshiro Y, Takaoka K. [Hepatic CYP3A activity in association with development of osteonecrosis of the femoral head]. Clin Calcium. 2007;17(6):902.
   PubMedGoogle Scholar